ArticleAdvances in therapy2024

Adherence, Persistence, Healthcare Resource Use, and Costs in Tofacitinib-Treated Patients with Psoriatic Arthritis: Data from Two United States Claims Databases.

Philip J Mease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.